MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Hygroscopic, deteriorates upon absorbing water. Store in original container with desiccant.

Provenance

This compatibility recommendation is derived from Cycloserine 250mg capsules (Neon Healthcare Ltd).

Stability Notes

No special precautions for storage.

Provenance

This compatibility recommendation is derived from Cyklokapron 500mg tablets (Viatris UK Healthcare Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 30mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 30mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 60mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Store in an airtight container. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Cymbalta 60mg gastro-resistant capsules (Eli Lilly and Company Ltd).

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Actiq lozenges with integral oromucosal applicator (Teva UK Ltd).

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Actiq lozenges with integral oromucosal applicator (Teva UK Ltd).

Stability Notes

Unsuitable for MCA as hygroscopic buccal tablets, which should not be swallowed.

Provenance

This compatibility recommendation is derived from Actiq lozenges with integral oromucosal applicator (Teva UK Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.